Cargando…
New technologies in the management of overactive bladder: current research and future prospects
Overactive bladder is characterized by frequency, urgency (wet or dry) and nocturia. These troublesome symptoms incur both a physiologic and economic cost, expected to be in excess of US$82 billion in the USA and Europe by the year 2020. Second-tier medicinal oral therapies for overactive bladder ab...
Autor principal: | Marinkovic, Serge P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484233/ https://www.ncbi.nlm.nih.gov/pubmed/31040883 http://dx.doi.org/10.1177/1756287219844669 |
Ejemplares similares
-
Current pharmacotherapy of overactive bladder
por: Kreydin, Evgenyi I., et al.
Publicado: (2021) -
Pharmacologic management of overactive bladder
por: Lam, Sum, et al.
Publicado: (2007) -
Update on the management of overactive bladder
por: Fontaine, Christina, et al.
Publicado: (2021) -
Recent advances in managing overactive bladder
por: Araklitis, George, et al.
Publicado: (2020) -
Mirabegron in the Management of Overactive Bladder Syndrome
por: O’Kane, Miriam, et al.
Publicado: (2022)